Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 20 January 2009, doi:10.1136/bmj.b207
Cite this as: BMJ 2009;338:b207
Susan Mayor
1 London
| The first 150 words of the full text of this article appear below. |
Lack of funding has prevented progress in UK stem cell research that is based on creating human-animal hybrid clones, despite legislation that allows the technique being passed a year ago, researchers warned this week.
Two of the three UK researchers who were granted licences last year to conduct research with human-animal hybrid stem cells, Stephen Minger at Kings College, London, and Lyle Armstrong at Newcastle Universitys centre for life, said that they had been unable to initiate or continue with early studies because research councils had turned down grant applications.
Dr Minger, senior lecturer in stem cell biology at Kings College, London, said that the Medical Research Council had turned down an application by his department for about £1m (
1.1m; $1.5m) to cover a three year project.
The aim was to develop stem cell lines from people with genetic forms of neurodegenerative conditions, including Alzheimers disease, Parkinsons disease, motor
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?